Jubilant Ingrevia growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+5.0%+1.0%−13.3%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+9.2%+23.3%−23.0%
+8.3%+26.8%−32.9%
+10.6%+37.3%−40.5%
+10.7%+37.5%−40.2%
+9.0%+6.3%+11.1%
+6.8%+6.9%+2.7%
+3.2%+18.2%−7.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

JUBLINGREA₹567.85

Jubilant Ingrevia Ltd.

· Chemicals
₹ CrorePeersVIDHIINGPARADEEPPCBLFACTOALIGPLPAUSHAKLTDTIRUMALCHMMcap ₹8,972 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—-13.3+1.0+5.0—
EBITDA Growth—-23.0+23.3+9.2—
EBIT Growth—-32.9+26.8+8.3—
Net Income Growth—-40.5+37.3+10.6—
EPS Growth—-40.2+37.5+10.7—
Total Assets Growth—+11.1+6.3+9.0—
Total Equity Growth—+2.7+6.9+6.8—
Cash from Operations Growth—-7.0+18.2+3.2—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.